SCHEMBL854325

SCHEMBL854325

IC1=C(OCc2ccccc2)C=CC[CH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.41
MAOB P27338 6/20 0.40
MAOA P21397 2/20 0.40
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
PTGS1 P23219 1/20 0.38
SLC6A2 P23975 1/20 0.38
CYP2C19 P33261 1/20 0.38
PTGS2 P35354 1/20 0.38
SLC6A3 Q01959 1/20 0.38
HIF1A Q16665 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7525635 0.78 MAOB (0.43) MAOBMAOALMNACYP1A2PTGS1
SCHEMBL5045555 0.76 LMNA (0.35) MAOBMAOALMNACYP1A2PTGS1
SCHEMBL5601610 0.71 TSHR (0.40) MAOBMAOALMNACYP1A2PTGS1
SCHEMBL7694567 0.70 LMNA (0.39) MAOBMAOALMNACYP1A2PTGS1
SCHEMBL22369114 0.68 L3MBTL1 (0.43) MAOBMAOALMNACYP1A2PTGS1
SCHEMBL2491022 0.64 HTT (0.41) APPMAOBMAOALMNACYP1A2
SCHEMBL31129630 0.63 NUDT1 (0.51) APPLMNACYP1A2PTGS1SLC6A2
SCHEMBL6469379 0.62 TSHR (0.52) MAOBMAOALMNACYP1A2PTGS1
SCHEMBL20755877 0.62 FFAR1 (0.57) APPMAOBTSHRL3MBTL1MAPT
SCHEMBL74678 0.62 MAPT (0.59) APPTSHRL3MBTL1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed